US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Bevacizumab

Reason Lack of assurance of sterility.

Pacifico National, Inc. dba AmEx Pharmacy D-1850-2019
Class II · Moderate risk Terminated

Bevacizumab

Reason Lack of assurance of sterility.

Pacifico National, Inc. dba AmEx Pharmacy D-1849-2019
Class II · Moderate risk Terminated

Fexofenadine HCl Tablets

Reason Failed Impurities/Degradation Specifications

Preferred Pharmaceuticals, Inc D-1877-2019
Class II · Moderate risk Terminated

Ascorbic Acid Sterile Injection Solution

Reason Labeling: Not Elsewhere Classified; product is labeled as "Non-Corn Source" however the product is from a corn source.

Atlas Pharmaceuticals, LLC NDC 71591-500-50 D-0144-2020
Class II · Moderate risk Terminated

Entropic Labs SARM RAD-140

Reason Marketed Without An Approved NDA/ANDA: product contains Selective Androgen Receptor Modulators (SARMs)

Tuscano and Delucia Group (DBA Entropic Labs) D-0800-2020
Class II · Moderate risk Terminated

Allergy

Reason Failed Impurities/Degradation Specifications

Aurolife Pharma, LLC NDC 53943-021-09 D-1874-2019
Class II · Moderate risk Terminated

Wal-Fex

Reason Failed Impurities/Degradation Specifications

Aurolife Pharma, LLC NDC 0363-0097-55 D-1873-2019
Class II · Moderate risk Terminated

Allergy

Reason Failed Impurities/Degradation Specifications

Aurolife Pharma, LLC NDC 58602-820-09 D-1872-2019
Class II · Moderate risk Terminated

Fexofenadine HCL Tablets USP

Reason Failed Impurities/Degradation Specifications

Aurolife Pharma, LLC D-1871-2019
Class II · Moderate risk Terminated

Fexofenadine Hydrochloride Tablets USP

Reason Failed Impurities/Degradation Specifications

Aurolife Pharma, LLC NDC 62011-0315-1 D-1870-2019
Class II · Moderate risk Terminated

Allergy Relief

Reason Failed Impurities/Degradation Specifications

Aurolife Pharma, LLC NDC 49035-995-62 D-1869-2019
Class II · Moderate risk Terminated

Fexofenadine Hydrochloride Tablets USP

Reason Failed Impurities/Degradation Specifications

Aurolife Pharma, LLC NDC 70677-0008-2 D-1868-2019
Class II · Moderate risk Terminated

fexofenadine hydrochloride tablets USP

Reason Failed Impurities/Degradation Specifications

Aurolife Pharma, LLC NDC 68196-976-91 D-1867-2019
Class II · Moderate risk Terminated

Allergy Relief

Reason Failed Impurities/Degradation Specifications

Aurolife Pharma, LLC NDC 46122-387-23 D-1866-2019
Class II · Moderate risk Terminated

Allergy Relief

Reason Failed Impurities/Degradation Specifications

Aurolife Pharma, LLC NDC 60000-409-53 D-1865-2019
Class II · Moderate risk Terminated

Relpax

Reason Microbial Contamination of Non-Sterile Products: contamination with Burkholderia and Pseudomonas.

Pfizer Inc. NDC 0049-2340-45 D-1845-2019
Class II · Moderate risk Terminated

S-Trimix

Reason Lack of Assurance of Sterility

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0296-2020
Class II · Moderate risk Terminated

S-Trimix

Reason Lack of Assurance of Sterility

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0295-2020